Disulfidptosis: a new target for metabolic cancer therapy

Altered metabolism is a hallmark of cancer and presents a vulnerability that can be exploited in cancer treatment. Regulated cell death (RCD) plays a crucial role in cancer metabolic therapy. A recent study has identified a new metabolic-related RCD known as disulfidptosis. Preclinical findings sugg...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Peijie, Zhou, Chuntao, Ding, Yuemin, Duan, Shiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134647/
https://www.ncbi.nlm.nih.gov/pubmed/37101248
http://dx.doi.org/10.1186/s13046-023-02675-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134647/
https://www.ncbi.nlm.nih.gov/pubmed/37101248
http://dx.doi.org/10.1186/s13046-023-02675-4

Ejemplares similares